Posted In: Drug Litigation

Over 9 million people take Johnson & Johnson’s antipsychotic drug Risperdal. Recent lawsuits allege that its manufacturers failed to properly warn about the risk to young male adolescents of developing gynecomastia. Gynecomastia is a condition defined by enlarged breasts in men. It is a condition that is often traumatic, both emotionally and financially, to those who suffer from it. Boys suffering from gynecomastia may also experience pain and/or nipple discharge.

Research has suggested that Risperdal could increase prolactin levels. Prolactin is a hormone that normally stimulates breast development in women. Young boys with increased levels of prolactin could similarly develop breasts.

As long-term effects of Risperdal have not been well documented in young children, parents and doctors deserve to know the risks prior to putting them in danger. There are currently over 100 Risperdal lawsuits pending claiming that young male adolescents grew breasts after using Risperdal. The first such case to head to trial was confidentially settled on the eve of trial.

The Risperdal attorneys at Slater Slater Schulman LLP are currently evaluating potential Risperdal lawsuits. If your son suffers from gynecomastia after using Risperdal, the attorneys at Slater Slater Schulman LLP are here to help. Please call us at 1-800-251-6990 or fill out the form on this page and someone from our office will contact you to discuss your case. The consultation is free of charge.

Medical Disclaimer: Please note that any change in medications should be made only after consulting with your doctor about the risks and benefits of doing so and should not be based on any information contained in this web site or on a commercial.

Sidebar Contact Form

Related Posts